Aluminum Chloride for Sweating: Evidence and Risks

Aluminum chloride hexahydrate is an antiperspirant active ingredient used in stronger topical products for focal excessive sweating. It reduces sweat locally by obstructing the outer part of eccrine sweat ducts.[1] Clinical studies support an on-treatment effect on palms, soles, and underarms, but the evidence varies by concentration, vehicle, body site, and study design.[2][3][4]

It is not a permanent gland-removal treatment. It is also not synonymous with every “clinical strength” antiperspirant, because current retail products use several different aluminum salts.

How aluminum chloride hexahydrate works#

Topical aluminum salts interact within the sweat duct and produce an obstruction that reduces sweat reaching the skin surface.[1] The mechanism is local and mechanical. It differs from anticholinergic medicines, which block acetylcholine signaling, and from procedures that physically target glands.

This explains two practical features. Benefit depends on continued topical use, and the formulation must reach the appropriate site without causing intolerable irritation. It also explains why a response while using the product should not be described as a cure.

What the palmar evidence shows#

A small controlled study applied 20% aluminum chloride hexahydrate in alcohol to palms and measured skin water loss with an evaporimeter. Treated palms had significantly less measured sweat during four weeks of treatment, but the difference was no longer significant after treatment stopped.[2]

The study provides objective support for temporary palmar sweat reduction. Its small size limits precision, and it cannot establish that 20% is the best concentration, that alcohol is the best vehicle, or that every person with sweaty hands will respond.

What the plantar evidence shows#

A randomized half-side trial enrolled 20 people with plantar hyperhidrosis. Participants used 12.5% and 30% aluminum chloride on opposite feet for six weeks. Both concentrations reduced sweat production, and the investigators recommended 12.5% because both were effective.[3]

That result is especially useful for correcting “stronger must be better” assumptions. It is still only one small foot study. It does not determine the right concentration for underarms or palms, and it does not compare current branded formulations.

What the axillary evidence shows#

An open-label study evaluated aluminum chloride hexahydrate in a salicylic acid gel among adults with moderate-to-severe primary axillary hyperhidrosis. Twenty-one of 29 evaluable participants were responders at week four; 18 of 25 were responders at week twelve.[4]

Because the study lacked a placebo group, it cannot separate the formulation’s effect from expectation, natural variation, or other influences as confidently as a randomized controlled trial. The vehicle also matters: salicylic acid gel findings should not be copied onto an alcohol solution or stick.

Concentration is only one part of a formulation#

Aluminum chloride hexahydrate appears in several strengths and vehicles. Water content, alcohol or gel base, drying behavior, and application site can affect both effectiveness and irritation. Percentages across different aluminum salts are not directly interchangeable.

Drysol is one branded 20% aluminum chloride solution identified in an FDA proprietary-name review.[5] Ingredient evidence helps explain its mechanism and body-site limitations, but product-specific directions still come from the current label.

For that product-specific interpretation, read the Drysol evidence review. For site-specific use, see the separate guides to hand antiperspirant and foot antiperspirant.

Irritation is the major limiting effect#

Burning, itching, redness, and dermatitis can occur with aluminum chloride products.[2][4] The acidic formulation and vehicle can contribute. Application to damp, broken, freshly shaved, or already irritated skin may worsen the problem.

Use only according to the exact label or clinician instructions. Do not create a stronger mixture, combine several aluminum products, or assume a schedule from one study applies to a different product. Stop and seek guidance if a significant reaction develops.

People with kidney disease should follow their product’s warning and consult a clinician. Broken skin, infection, ulceration, and severe dermatitis need a different answer than more antiperspirant.

When the ingredient is not enough#

Persistent focal hyperhidrosis may need a body-site-specific escalation. Palms and soles may move toward iontophoresis; underarms have prescription topical medicines, injections, and procedures. Sudden, generalized, nighttime, or asymmetric sweating should be evaluated for another cause before symptom suppression is intensified.

Frequently asked questions#

Is aluminum chloride hexahydrate the same as aluminum chlorohydrate?#

No. They are different aluminum salts. Do not compare their percentages directly or assume their formulas, labels, and evidence are interchangeable.

Does aluminum chloride hexahydrate permanently stop sweating?#

No. The palmar study found benefit during treatment and loss of the significant difference after treatment stopped.[2] The ingredient temporarily reduces local sweat flow.

Is a higher concentration always more effective?#

No. In a 20-person plantar trial, both 12.5% and 30% reduced sweating, and the investigators favored the lower concentration.[3]

Is aluminum chloride evidence the same for every body site?#

No. Palmar, plantar, and axillary studies involve different skin, formulations, and designs. Claims should remain attached to the body site actually studied.

This article is an ingredient evidence summary, not a diagnosis or a product-specific application protocol.

References#

1. Hölzle E. Topical pharmacological treatment. Curr Probl Dermatol. 2002;30:30-43. PubMed PMID 12471696

2. Goh CL. Aluminum chloride hexahydrate versus palmar hyperhidrosis. Int J Dermatol. 1990;29(5):368-370. PubMed PMID 2361796

3. Streker M, et al. Hyperhidrosis plantaris: a randomized half-side trial of aluminum chloride concentrations. J Dtsch Dermatol Ges. 2012;10(2):115-119. PubMed PMID 21848980

4. Flanagan KH, Glaser DA. An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis. J Drugs Dermatol. 2009;8(5):477-480. PubMed PMID 19537371

5. U.S. Food and Drug Administration. Drysol proprietary-name review. FDA review PDF